Clinical outcomes based on MET expression level in METEOR, a randomized phase 3 trial of cabozantinib versus everolimus in advanced renal cell carcinoma (RCC) Meeting Abstract
| Authors: | Powles, T.; Escudier, B.; Motzer, R. J.; Tannir, N. M.; Scheffold, C.; Aftab, D. T.; Chouieri, T. K. |
| Abstract Title: | Clinical outcomes based on MET expression level in METEOR, a randomized phase 3 trial of cabozantinib versus everolimus in advanced renal cell carcinoma (RCC) |
| Meeting Title: | 15th International Kidney Cancer Symposium |
| Journal Title: | BJU International |
| Volume: | 118 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2016 Nov 4-5 |
| Meeting Location: | Miami, FL |
| ISSN: | 1464-4096 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2016-12-01 |
| Start Page: | 4 |
| Language: | English |
| ACCESSION: | WOS:000388478200002 |
| PROVIDER: | wos |
| PUBMED: | 27860174 |
| DOI: | 10.1111/bju.13694 |
| Notes: | Meeting Abstract -- Source: Wos |
